Maximus, Inc. (NYSE:MMS) Holdings Lowered by Hsbc Holdings PLC

Hsbc Holdings PLC decreased its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 49.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,492 shares of the health services provider's stock after selling 17,753 shares during the quarter. Hsbc Holdings PLC's holdings in Maximus were worth $1,380,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of MMS. Tower Research Capital LLC TRC grew its holdings in Maximus by 153.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,296 shares of the health services provider's stock valued at $470,000 after purchasing an additional 3,807 shares in the last quarter. MetLife Investment Management LLC boosted its position in Maximus by 6.5% in the 4th quarter. MetLife Investment Management LLC now owns 68,689 shares of the health services provider's stock valued at $5,128,000 after buying an additional 4,219 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after acquiring an additional 177,075 shares in the last quarter. First Trust Advisors LP increased its position in shares of Maximus by 9.9% during the fourth quarter. First Trust Advisors LP now owns 625,234 shares of the health services provider's stock worth $46,674,000 after acquiring an additional 56,490 shares during the last quarter. Finally, Dean Investment Associates LLC boosted its holdings in Maximus by 58.5% in the fourth quarter. Dean Investment Associates LLC now owns 58,644 shares of the health services provider's stock valued at $4,378,000 after purchasing an additional 21,650 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Maximus Stock Up 1.0 %

NYSE MMS traded up $0.64 on Wednesday, hitting $67.11. 193,356 shares of the stock traded hands, compared to its average volume of 558,029. The company has a market capitalization of $3.80 billion, a P/E ratio of 14.42 and a beta of 0.61. The stock has a 50-day moving average of $67.64 and a 200 day moving average of $73.36. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. Maximus's dividend payout ratio is presently 25.81%.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.